As mentioned above, increased NfL levels can be detected in the CSF or blood of patients with neurologic disorders causing axonal damage, such as MS (Lycke et al., 1998[64]; Malmeström et al., 2003[65]). This evidence concerns the gene NEFL and myeloid sarcoma.